These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32437964)

  • 41. Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas.
    Doglioni C; Gambacorta M; Zamboni G; Coggi G; Viale G
    Am J Pathol; 1990 Nov; 137(5):999-1005. PubMed ID: 2240168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis.
    Andreasi V; Ricci C; Partelli S; Guarneri G; Ingaldi C; Muffatti F; Crippa S; Casadei R; Falconi M
    J Endocrinol Invest; 2022 Apr; 45(4):705-718. PubMed ID: 34773595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances.
    Guilmette JM; Nosé V
    Adv Anat Pathol; 2019 Jan; 26(1):13-30. PubMed ID: 29912000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
    Bocchini M; Nicolini F; Severi S; Bongiovanni A; Ibrahim T; Simonetti G; Grassi I; Mazza M
    Front Oncol; 2020; 10():831. PubMed ID: 32537434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular degradation of the C-peptide of proinsulin, in a human insulinoma: identification of sites of cleavage and evidence for a role for cathepsin B.
    Conlon JM; Höög A; Grimelius L
    Pancreas; 1995 Mar; 10(2):167-72. PubMed ID: 7716141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging.
    De Robertis R; D'Onofrio M; Zamboni G; Tinazzi Martini P; Gobbo S; Capelli P; Butturini G; Girelli R; Ortolani S; Cingarlini S; Pederzoli P; Scarpa A
    Neuroendocrinology; 2016; 103(6):758-70. PubMed ID: 26646652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proinsulin and insulin release with a human insulinoma and adjacent nonadenomatous pancreas.
    Gutman RA; Fink G; Shapiro JR; Selawry H; Recant L
    J Clin Endocrinol Metab; 1973 May; 36(5):978-87. PubMed ID: 4349051
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.
    Pérez-Pevida B; Idoate MÁ; Fernández-Landázuri S; Varo N; Escalada J
    Endocr Pathol; 2016 Mar; 27(1):50-4. PubMed ID: 26801953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple proinsulin-secreting tumors of the pancreas treated by laparoscopic distal pancreatectomy and splenectomy.
    Clark G; Sadur C; Puligandla B
    World J Surg; 2009 Mar; 33(3):397-9. PubMed ID: 18949512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma.
    Koivisto VA; Yki-Järvinen H; Hartling SG; Pelkonen R
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1117-20. PubMed ID: 3020076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.
    Fang JM; Shi J
    Arch Pathol Lab Med; 2019 Nov; 143(11):1317-1326. PubMed ID: 31509453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells.
    Fehmann HC; Habener JF
    Endocrinology; 1992 Jan; 130(1):159-66. PubMed ID: 1309325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients.
    Qu Y; Li H; Wang X; Chen Y; Guo Q; Pei Y; Du J; Dou J; Ba J; Lv Z; Mu Y
    Int J Endocrinol; 2020; 2020():1030518. PubMed ID: 33204258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional and morphologic characterization of human insulinomas.
    Berger M; Bordi C; Cüppers HJ; Berchtold P; Gries FA; Münterfering H; Sailer R; Zimmermann H; Orci L
    Diabetes; 1983 Oct; 32(10):921-31. PubMed ID: 6311653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatic B-cells secrete a range of novel peptides besides insulin.
    Sopwith AM; Hales CN; Hutton JC
    Biochim Biophys Acta; 1984 Apr; 803(4):342-5. PubMed ID: 6322863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biosynthesis of betagranin in pancreatic beta-cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin.
    Hutton JC; Davidson HW; Grimaldi KA; Peshavaria M
    Biochem J; 1987 Jun; 244(2):449-56. PubMed ID: 3311030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma.
    Partelli S; Tamburrino D; Cherif R; Muffatti F; Moggia E; Gaujoux S; Sauvanet A; Falconi M; Fusai G
    Pancreas; 2019 Apr; 48(4):504-509. PubMed ID: 30946244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors.
    Li MX; Li QY; Xiao M; Wan DL; Chen XH; Zhou L; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):538-545. PubMed ID: 30981633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin and Glucagon mRNA Expression and Prohormone Convertase Immunoreactivity in Normal and Neoplastic Pancreatic Endocrine Tissue.
    Rodacker M; Jin L; Zhang S; Lloyd RV
    Endocr Pathol; 2000; 11(2):179-183. PubMed ID: 12114824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
    Panzuto F; Pusceddu S; Faggiano A; Rinzivillo M; Brighi N; Prinzi N; Riccardi F; Iannicelli E; Maggio I; Femia D; Tafuto S; Manuzzi L; Di Sarno A; Annibale B; de Braud F; Campana D;
    Pancreatology; 2019 Dec; 19(8):1067-1073. PubMed ID: 31587962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.